ZA885095B - Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles - Google Patents

Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Info

Publication number
ZA885095B
ZA885095B ZA885095A ZA885095A ZA885095B ZA 885095 B ZA885095 B ZA 885095B ZA 885095 A ZA885095 A ZA 885095A ZA 885095 A ZA885095 A ZA 885095A ZA 885095 B ZA885095 B ZA 885095B
Authority
ZA
South Africa
Prior art keywords
double
tumor cell
stranded rna
metabolic pathways
virus growth
Prior art date
Application number
ZA885095A
Other languages
English (en)
Inventor
William A Carter
A Carter William
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of ZA885095B publication Critical patent/ZA885095B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA885095A 1987-07-17 1988-07-14 Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles ZA885095B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7464987A 1987-07-17 1987-07-17

Publications (1)

Publication Number Publication Date
ZA885095B true ZA885095B (en) 1989-07-26

Family

ID=22120800

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885095A ZA885095B (en) 1987-07-17 1988-07-14 Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Country Status (18)

Country Link
EP (2) EP0299745B1 (xx)
JP (1) JPH01104015A (xx)
KR (1) KR970007903B1 (xx)
CN (1) CN1032741A (xx)
AT (1) ATE123222T1 (xx)
AU (3) AU1820388A (xx)
CA (1) CA1331345C (xx)
DE (1) DE3853898T2 (xx)
DK (1) DK363088A (xx)
ES (1) ES2075835T3 (xx)
FI (1) FI883351A (xx)
GR (1) GR3017271T3 (xx)
IE (1) IE75896B1 (xx)
IL (1) IL86865A (xx)
NO (1) NO882854L (xx)
PT (1) PT87997B (xx)
RU (1) RU1838419C (xx)
ZA (1) ZA885095B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72103B1 (en) * 1987-08-12 1997-03-12 Hem Res Inc Promotion of host defense by systemic dsRNA treatment
NO883868L (no) * 1987-09-04 1989-03-06 Hem Res Inc Fremgangsmaate for diagnostisering av dsrna-mangeltilstander, samt fremgangsmaate for fremstilling av preparater for diagnostisering og behandling av slike tilstander.
EP0306347B1 (en) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnosis of double-stranded RNA deficiency states
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
ATE103493T1 (de) * 1988-07-07 1994-04-15 Hem Pharma Corp Diagnose und behandlung chronischer ermuedungserscheinungen.
AU6740590A (en) * 1989-10-11 1991-05-16 Hem Research, Inc. Protection from shock subsequent to injury by double-stranded rnas
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
JPH07501787A (ja) * 1991-07-16 1995-02-23 ヘム・ファーマスーティカル・コーポレーション サイトカイン機能不全の緩和法および診断法
US5985565A (en) 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
TW524693B (en) * 1997-10-16 2003-03-21 Nippon Shinyaku Co Ltd Cancer cell nuclease activator
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
CN100358534C (zh) * 2005-11-21 2008-01-02 北京百林康源生物技术有限责任公司 错位双链寡核苷酸在制备治疗禽流感病毒感染的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
ATE123222T1 (de) 1995-06-15
FI883351A0 (fi) 1988-07-14
CN1032741A (zh) 1989-05-10
PT87997B (pt) 1995-03-01
EP0525917A2 (en) 1993-02-03
IE75896B1 (en) 1997-09-24
DK363088A (da) 1989-01-18
EP0525917A3 (en) 1993-02-24
CA1331345C (en) 1994-08-09
DE3853898T2 (de) 1996-02-29
PT87997A (pt) 1989-06-30
RU1838419C (ru) 1993-08-30
EP0299745A2 (en) 1989-01-18
DE3853898D1 (de) 1995-07-06
NO882854L (no) 1989-01-18
ES2075835T3 (es) 1995-10-16
EP0299745B1 (en) 1995-05-31
AU1619092A (en) 1992-08-13
AU1820388A (en) 1989-01-19
IL86865A0 (en) 1988-11-30
AU1502695A (en) 1995-07-06
KR890002420A (ko) 1989-04-10
GR3017271T3 (en) 1995-11-30
KR970007903B1 (ko) 1997-05-17
JPH01104015A (ja) 1989-04-21
IE881895L (en) 1989-01-17
NO882854D0 (no) 1988-06-28
IL86865A (en) 1993-06-10
EP0299745A3 (en) 1989-12-06
DK363088D0 (da) 1988-06-30
FI883351A (fi) 1989-01-18

Similar Documents

Publication Publication Date Title
Althaus et al. Effects of altered [ADP-ribose] n metabolism on expression of fetal functions by adult hepatocytes
EP0299745A3 (en) Double-stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
EP0288163A3 (en) Oligodeoxynucleotides as inhibitors of the replication of retroviruses and the expression of oncogenes
EP0285950A3 (en) A drug delivery conjugate
EP0341904A3 (en) Method for predicting the effectiveness of antineoplastic therapy in individual patients
WO2002061033A3 (en) Transfection of human embryonic stem cells
HK1047129A1 (en) Sequence-specific dna recombination in eukaryotic cells
MX9801264A (es) Control de la expresion del gen de cd44 para uso terapeutico.
NO179953C (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opplösning, samt engangs enzymelektrode
WO1999015643A3 (en) ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE
IE830945L (en) Process for obtaining permanently culturable animal and¹human cell lines
ES8800725A1 (es) Un procedimiento para producir un anticuerpo monoclonal
DE3272969D1 (en) Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells
ES8304801A1 (es) Un metodo para preparar una vacuna contra vibrio anguillarum
MD1119G2 (ro) Metodă de tratament al afecţiunilor inflamatorii ale organelor genitale feminine
WO1993013204A3 (de) Mittel zur stimulierung der teilungsaktivität tierischer zellen
HUT47747A (en) Method for correction defective ways of metabolism related to cycles of growth of spontaneous tomour-cells and viruses, with double-stranded rns
ZHUKOV et al. An attempt to prevent weather-aggravated cardiovascular diseases
JPS53127888A (en) Preparation of glycerol-dehydrogenase
JPS5639795A (en) Preparation of interferon
JPS54157814A (en) Preparation of nea
ES2007775A6 (es) Procedimiento para la obtencion de fibronectina del plasma y de fracciones plasmaticas.
ZA88554B (en) High level expression in e.coli of soluble mature hil-1beta and derivatives with altered biological activity